chore: daily discovery 2026-04-04
This commit is contained in:
github-actions[bot]
parent
a8ccb0e396
commit
1e06895946
|
|
@ -0,0 +1,66 @@
|
|||
{
|
||||
"date": "2026-04-04",
|
||||
"llm_provider": "google",
|
||||
"recommendations": [
|
||||
{
|
||||
"ticker": "PAGS",
|
||||
"rank": 1,
|
||||
"company_name": "PagSeguro Digital Ltd.",
|
||||
"description": "PagSeguro Digital Ltd. engages in the provision of financial and payment solutions for consumers, entrepreneurs, and small/medium businesses in Brazil.",
|
||||
"strategy_match": "insider_buying",
|
||||
"pipeline": "insider_buying",
|
||||
"final_score": 88,
|
||||
"confidence": 8,
|
||||
"risk_level": "moderate",
|
||||
"reason": "Director Luis Frias executed a massive $4.96M insider purchase, providing a strong fundamental floor for the stock. This is corroborated by highly unusual bullish options flow, highlighted by a staggering 0.021 P/C ratio and heavy call buying at the $14 strike. Technicals are aligning with the accumulation, showing a MACD bullish crossover and price action holding above the 20 EMA and VWAP. The risk/reward is highly favorable given the low valuation (P/E 7.55), though failure to break the 50 SMA at $10.51 could stall momentum.",
|
||||
"entry_price": 10.34000015258789,
|
||||
"discovery_date": "2026-04-04",
|
||||
"status": "open"
|
||||
},
|
||||
{
|
||||
"ticker": "ZBIO",
|
||||
"rank": 2,
|
||||
"company_name": "Zenas BioPharma, Inc.",
|
||||
"description": "Zenas BioPharma, Inc. is a clinical-stage biopharma company developing immunology-based therapies.",
|
||||
"strategy_match": "insider_buying",
|
||||
"pipeline": "insider_buying",
|
||||
"final_score": 85,
|
||||
"confidence": 7,
|
||||
"risk_level": "high",
|
||||
"reason": "ZBIO is experiencing aggressive cluster buying, with three insiders\u2014including the CEO ($1.0M) and a 10% owner ($3.0M)\u2014purchasing over $5.5M in shares. This heavy insider accumulation is a massive vote of confidence and directly challenges the elevated short interest of 21.1%. Short-term momentum is accelerating, evidenced by an intraday jump of +6.4% and the price crossing above both the VWAP and 20 EMA. While the setup is primed for a squeeze, the stock's pre-revenue status and high volatility (ATR 9.1%) present substantial fundamental risks.",
|
||||
"entry_price": 21.459999084472656,
|
||||
"discovery_date": "2026-04-04",
|
||||
"status": "open"
|
||||
},
|
||||
{
|
||||
"ticker": "PACB",
|
||||
"rank": 3,
|
||||
"company_name": "Pacific Biosciences of California, Inc.",
|
||||
"description": "Pacific Biosciences of California, Inc. designs and manufactures sequencing solutions to resolve genetically complex problems.",
|
||||
"strategy_match": "earnings_play",
|
||||
"pipeline": "earnings_play",
|
||||
"final_score": 70,
|
||||
"confidence": 6,
|
||||
"risk_level": "speculative",
|
||||
"reason": "PACB presents a compelling binary setup heading into its earnings report in three days. The options market is aggressively positioning for an upside move, reflected by an extremely bullish P/C volume ratio of 0.086. Combined with a high short interest of 15.6%, any positive surprise or forward guidance could trigger a violent short squeeze. A recent MACD bullish crossover and an intraday bounce of +3.9% indicate pre-earnings accumulation, though the underlying cash burn and strong macro downtrend pose severe risks if earnings disappoint.",
|
||||
"entry_price": 1.340000033378601,
|
||||
"discovery_date": "2026-04-04",
|
||||
"status": "open"
|
||||
},
|
||||
{
|
||||
"ticker": "NNOX",
|
||||
"rank": 4,
|
||||
"company_name": "Nano-X Imaging Ltd.",
|
||||
"description": "Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source and provides teleradiology services.",
|
||||
"strategy_match": "earnings_play",
|
||||
"pipeline": "earnings_play",
|
||||
"final_score": 60,
|
||||
"confidence": 5,
|
||||
"risk_level": "speculative",
|
||||
"reason": "With earnings arriving in just two days, NNOX is flashing contrarian bullish signals driven by options flow and short positioning. The options P/C ratio sits at a heavily skewed 0.241, suggesting speculators are betting on an earnings beat or short squeeze. A short interest of 13.3% provides the fuel for a potential rapid upward rerating. However, the company's operating margin of -413% and high volatility (ATR 6.3%) make this a strictly speculative, binary trade heavily reliant on the upcoming catalyst.",
|
||||
"entry_price": 2.4100000858306885,
|
||||
"discovery_date": "2026-04-04",
|
||||
"status": "open"
|
||||
}
|
||||
]
|
||||
}
|
||||
File diff suppressed because it is too large
Load Diff
|
|
@ -34,46 +34,46 @@
|
|||
"insider_buying": {
|
||||
"count": 163,
|
||||
"wins_1d": 61,
|
||||
"losses_1d": 98,
|
||||
"wins_7d": 69,
|
||||
"losses_1d": 101,
|
||||
"wins_7d": 71,
|
||||
"losses_7d": 86,
|
||||
"wins_30d": 22,
|
||||
"losses_30d": 55,
|
||||
"avg_return_1d": -0.09,
|
||||
"avg_return_7d": -0.57,
|
||||
"avg_return_7d": -0.53,
|
||||
"avg_return_30d": -1.47,
|
||||
"win_rate_1d": 38.4,
|
||||
"win_rate_7d": 44.5,
|
||||
"win_rate_1d": 37.7,
|
||||
"win_rate_7d": 45.2,
|
||||
"win_rate_30d": 28.6
|
||||
},
|
||||
"options_flow": {
|
||||
"count": 89,
|
||||
"wins_1d": 30,
|
||||
"losses_1d": 59,
|
||||
"wins_7d": 35,
|
||||
"wins_7d": 38,
|
||||
"losses_7d": 48,
|
||||
"wins_30d": 18,
|
||||
"losses_30d": 42,
|
||||
"avg_return_1d": 0.05,
|
||||
"avg_return_7d": -1.33,
|
||||
"avg_return_7d": -1.12,
|
||||
"avg_return_30d": -3.06,
|
||||
"win_rate_1d": 33.7,
|
||||
"win_rate_7d": 42.2,
|
||||
"win_rate_7d": 44.2,
|
||||
"win_rate_30d": 30.0
|
||||
},
|
||||
"earnings_play": {
|
||||
"count": 57,
|
||||
"wins_1d": 20,
|
||||
"losses_1d": 35,
|
||||
"wins_7d": 21,
|
||||
"losses_1d": 37,
|
||||
"wins_7d": 22,
|
||||
"losses_7d": 33,
|
||||
"wins_30d": 20,
|
||||
"losses_30d": 25,
|
||||
"avg_return_1d": -0.79,
|
||||
"avg_return_7d": -2.23,
|
||||
"avg_return_1d": -0.76,
|
||||
"avg_return_7d": -2.03,
|
||||
"avg_return_30d": -4.24,
|
||||
"win_rate_1d": 36.4,
|
||||
"win_rate_7d": 38.9,
|
||||
"win_rate_1d": 35.1,
|
||||
"win_rate_7d": 40.0,
|
||||
"win_rate_30d": 44.4
|
||||
},
|
||||
"contrarian_value": {
|
||||
|
|
@ -94,12 +94,12 @@
|
|||
"news_catalyst": {
|
||||
"count": 7,
|
||||
"wins_1d": 0,
|
||||
"losses_1d": 6,
|
||||
"losses_1d": 7,
|
||||
"wins_7d": 0,
|
||||
"losses_7d": 6,
|
||||
"wins_30d": 1,
|
||||
"losses_30d": 3,
|
||||
"avg_return_1d": -7.06,
|
||||
"avg_return_1d": -6.05,
|
||||
"avg_return_7d": -8.14,
|
||||
"avg_return_30d": -17.5,
|
||||
"win_rate_1d": 0.0,
|
||||
|
|
@ -140,15 +140,15 @@
|
|||
"count": 25,
|
||||
"wins_1d": 7,
|
||||
"losses_1d": 18,
|
||||
"wins_7d": 11,
|
||||
"wins_7d": 12,
|
||||
"losses_7d": 13,
|
||||
"wins_30d": 4,
|
||||
"losses_30d": 14,
|
||||
"avg_return_1d": -0.02,
|
||||
"avg_return_7d": -1.12,
|
||||
"avg_return_7d": -0.9,
|
||||
"avg_return_30d": -4.45,
|
||||
"win_rate_1d": 28.0,
|
||||
"win_rate_7d": 45.8,
|
||||
"win_rate_7d": 48.0,
|
||||
"win_rate_30d": 22.2
|
||||
},
|
||||
"ipo_opportunity": {
|
||||
|
|
@ -198,16 +198,16 @@
|
|||
}
|
||||
},
|
||||
"overall_1d": {
|
||||
"count": 554,
|
||||
"count": 560,
|
||||
"wins": 210,
|
||||
"avg_return": -0.33,
|
||||
"win_rate": 37.9
|
||||
"win_rate": 37.5
|
||||
},
|
||||
"overall_7d": {
|
||||
"count": 541,
|
||||
"wins": 222,
|
||||
"avg_return": -1.25,
|
||||
"win_rate": 41.0
|
||||
"count": 548,
|
||||
"wins": 229,
|
||||
"avg_return": -1.17,
|
||||
"win_rate": 41.8
|
||||
},
|
||||
"overall_30d": {
|
||||
"count": 405,
|
||||
|
|
|
|||
Loading…
Reference in New Issue